"Neurofibromatosis 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An autosomal dominant disorder characterized by a high incidence of bilateral acoustic neuromas as well as schwannomas (NEURILEMMOMA) of other cranial and peripheral nerves, and other benign intracranial tumors including meningiomas, ependymomas, spinal neurofibromas, and gliomas. The disease has been linked to mutations of the NF2 gene (GENES, NEUROFIBROMATOSIS 2) on chromosome 22 (22q12) and usually presents clinically in the first or second decade of life.
| Descriptor ID |
D016518
|
| MeSH Number(s) |
C04.557.465.625.650.595.610.500 C04.557.580.600.580.590.655 C04.557.580.600.610.595.610.500 C04.700.645.655 C09.218.807.800.675.500 C09.647.675.500 C10.292.225.750.500 C10.292.910.600.500 C10.562.600.750 C10.574.500.549.700 C16.320.400.560.700 C16.320.700.645.655
|
| Concept/Terms |
Neurofibromatosis 2- Neurofibromatosis 2
- Neurofibromatosis, Central, NF2
- Neurofibromatosis, Central, NF 2
- Bilateral Acoustic Neurofibromatosis
- Acoustic Neurofibromatoses, Bilateral
- Acoustic Neurofibromatosis, Bilateral
- Bilateral Acoustic Neurofibromatoses
- Neurofibromatoses, Bilateral Acoustic
- Neurofibromatosis, Bilateral Acoustic
- Neurofibromatosis II
- Neurofibromatosis IIs
- Neurofibromatosis, central type
- Neurofibromatosis Type 2
- Neurofibromatosis, Type II
- Neurofibromatoses, Type II
- Type II Neurofibromatoses
- Type II Neurofibromatosis
- Neurofibromatosis, Type 2
- Neurofibromatoses, Type 2
- Type 2 Neurofibromatoses
- Type 2 Neurofibromatosis
- NF2 (Neurofibromatosis 2)
- NF2s (Neurofibromatosis 2)
- Neurofibromatosis, Central NF2
- Central NF2 Neurofibromatoses
- Central NF2 Neurofibromatosis
- Neurofibromatoses, Central NF2
- Central Neurofibromatosis
- Central Neurofibromatoses
- Neurofibromatoses, Central
- Neurofibromatosis, Central
- Neurofibromatosis, Acoustic, Bilateral
- Neurofibromatosis Type II
Neuroma, Acoustic, Bilateral- Neuroma, Acoustic, Bilateral
- Acoustic Neurinoma, Bilateral
- Acoustic Neurinomas, Bilateral
- Bilateral Acoustic Neurinoma
- Bilateral Acoustic Neurinomas
- Neurinoma, Bilateral Acoustic
- Neurinomas, Bilateral Acoustic
Schwannoma, Acoustic, Bilateral- Schwannoma, Acoustic, Bilateral
- Acoustic Schwannomas, Bilateral
- Acoustic Schwannoma, Bilateral
- Bilateral Acoustic Schwannoma
- Bilateral Acoustic Schwannomas
- Schwannoma, Bilateral Acoustic
- Schwannomas, Bilateral Acoustic
Familial Acoustic Neuromas- Familial Acoustic Neuromas
- Acoustic Neuroma, Familial
- Acoustic Neuromas, Familial
- Familial Acoustic Neuroma
- Neuroma, Familial Acoustic
- Neuromas, Familial Acoustic
|
Below are MeSH descriptors whose meaning is more general than "Neurofibromatosis 2".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Neoplasms, Germ Cell and Embryonal [C04.557.465]
- Neuroectodermal Tumors [C04.557.465.625]
- Neuroendocrine Tumors [C04.557.465.625.650]
- Neurilemmoma [C04.557.465.625.650.595]
- Neuroma, Acoustic [C04.557.465.625.650.595.610]
- Neurofibromatosis 2 [C04.557.465.625.650.595.610.500]
- Neoplasms, Nerve Tissue [C04.557.580]
- Nerve Sheath Neoplasms [C04.557.580.600]
- Neurofibroma [C04.557.580.600.580]
- Neurofibromatoses [C04.557.580.600.580.590]
- Neurofibromatosis 2 [C04.557.580.600.580.590.655]
- Neuroma [C04.557.580.600.610]
- Neurilemmoma [C04.557.580.600.610.595]
- Neuroma, Acoustic [C04.557.580.600.610.595.610]
- Neurofibromatosis 2 [C04.557.580.600.610.595.610.500]
- Neoplastic Syndromes, Hereditary [C04.700]
- Neurofibromatoses [C04.700.645]
- Neurofibromatosis 2 [C04.700.645.655]
- Otorhinolaryngologic Diseases [C09]
- Ear Diseases [C09.218]
- Retrocochlear Diseases [C09.218.807]
- Vestibulocochlear Nerve Diseases [C09.218.807.800]
- Neuroma, Acoustic [C09.218.807.800.675]
- Neurofibromatosis 2 [C09.218.807.800.675.500]
- Otorhinolaryngologic Neoplasms [C09.647]
- Neuroma, Acoustic [C09.647.675]
- Neurofibromatosis 2 [C09.647.675.500]
- Nervous System Diseases [C10]
- Cranial Nerve Diseases [C10.292]
- Cranial Nerve Neoplasms [C10.292.225]
- Neuroma, Acoustic [C10.292.225.750]
- Neurofibromatosis 2 [C10.292.225.750.500]
- Vestibulocochlear Nerve Diseases [C10.292.910]
- Neuroma, Acoustic [C10.292.910.600]
- Neurofibromatosis 2 [C10.292.910.600.500]
- Neurocutaneous Syndromes [C10.562]
- Neurofibromatoses [C10.562.600]
- Neurofibromatosis 2 [C10.562.600.750]
- Neurodegenerative Diseases [C10.574]
- Heredodegenerative Disorders, Nervous System [C10.574.500]
- Neurofibromatoses [C10.574.500.549]
- Neurofibromatosis 2 [C10.574.500.549.700]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Heredodegenerative Disorders, Nervous System [C16.320.400]
- Neurofibromatoses [C16.320.400.560]
- Neurofibromatosis 2 [C16.320.400.560.700]
- Neoplastic Syndromes, Hereditary [C16.320.700]
- Neurofibromatoses [C16.320.700.645]
- Neurofibromatosis 2 [C16.320.700.645.655]
Below are MeSH descriptors whose meaning is more specific than "Neurofibromatosis 2".
This graph shows the total number of publications written about "Neurofibromatosis 2" by people in this website by year, and whether "Neurofibromatosis 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 2 | 0 | 2 |
| 2018 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neurofibromatosis 2" by people in Profiles.
-
Update on Cancer and Central Nervous System Tumor Surveillance in Pediatric NF2-, SMARCB1-, and LZTR1-Related Schwannomatosis. Clin Cancer Res. 2025 Apr 14; 31(8):1400-1406.
-
Pediatric laryngeal electromyography technique for vocal fold immobility using bipolar double hookwire electrodes. Int J Pediatr Otorhinolaryngol. 2019 Apr; 119:75-78.
-
2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. Am J Med Genet A. 2018 05; 176(5):1258-1269.
-
Calvarial mass as a presenting feature of neurofibromatosis type 2 in a pediatric patient. Am J Med Genet A. 2018 01; 176(1):246-247.
-
Clinical Reasoning: A common cause for Phelan-McDermid syndrome and neurofibromatosis type 2: One ring to bind them. Neurology. 2017 10 24; 89(17):e205-e209.
-
Combining curcumin (diferuloylmethane) and heat shock protein inhibition for neurofibromatosis 2 treatment: analysis of response and resistance pathways. Mol Cancer Ther. 2011 Nov; 10(11):2094-103.
-
Epiretinal membranes indicate a severe phenotype of neurofibromatosis type 2. Retina. 2010 Apr; 30(4 Suppl):S51-8.
-
VprBP targets Merlin to the Roc1-Cul4A-DDB1 E3 ligase complex for degradation. Oncogene. 2008 Jul 03; 27(29):4056-64.
-
Optical coherence tomography characteristics of epiretinal membranes in neurofibromatosis 2. Ophthalmic Surg Lasers Imaging. 2008 Jan-Feb; 39(1):73-7.